Page 99 - 《中国药房》2022年14期

culating utility decrements associated with an adverse 812-821.
event：marginal Tobit and CLAD coefficients should be [11] SHINGLER S L，SWINBURN P，LLOYD A，et al. Elicita-
used with caution[J]. Med Decis Making，2011，31（6）： tion of health state utilities in soft tissue sarcoma[J]. Qual
790-799. Life Res，2013，22（7）：1697-1706.
[ 4 ] CLARKE P M，GRAY A M，BRIGGS A，et al. A model to [12] SWINBURN P，LLOYD A，NATHAN P，et al. Elicitation
estimate the lifetime health outcomes of patients with type of health state utilities in metastatic renal cell carcinoma[J].
2 diabetes：the United Kingdom prospective diabetes study Curr Med Res Opin，2010，26（5）：1091-1096.
（UKPDS）outcomes model（UKPDS no. 68）[J]. Diabeto- [13] CHOU T C，CHIANG S C，KO Y. Health state utilities for
logia，2004，47（10）：1747-1759. metastatic breast cancer in Taiwan[J]. Breast，2020，51：
[ 5 ] FREEMAN K，CONNOCK M，CUMMINS E，et al. Fluo- 57-64.
rouracil plasma monitoring：systematic review and eco- [14] DEGELING K，VU M，KOFFIJBERG H，et al. Health
nomic evaluation of the My5-FU assay for guiding dose economic models for metastatic colorectal cancer：a metho-
adjustment in patients receiving fluorouracil chemotherapy dological review[J]. Pharmacoeconomics，2020，38（7）：
by continuous infusion[J]. Health Technol Assess，2015， 683-713.
19（91）：1-321，Ⅴ-Ⅵ. [15] CHISAKI Y，KUWADA Y，MATSUMURA C，et al. Cost-
[ 6 ] HALL F，DE FREITAS H M，KERR C，et al. Estimating effectiveness analysis of atezolizumab plus nab-paclitaxel
utilities/disutilities for high-risk metastatic hormone-sensi- for advanced PD-L1 positive triple-negative breast cancer
tive prostate cancer （mHSPC） and treatment-related in Japan[J]. Clin Drug Investig，2021，41（4）：381-389.
adverse events[J]. Qual Life Res，2019，28（5）：1191- [16] 卢钰琼，代展菁，路云，等.健康状态负效用值测量结果合
1199. 并方法及影响因素研究：以抗肿瘤药所致腹泻为例[J].
[ 7 ] PAN C W，SUN H P，ZHOU H J，et al. Valuing health- 中国药房，2022，33（8）：975-980，986.
related quality of life in type 2 diabetes patients in China[J]. [17] 刘国恩.中国药物经济学评价指南：2020 版[M].北京：中
Med Decis Making，2016，36（2）：234-241. 国市场出版社，2020：1-299.
[ 8 ] PAPAIOANNOU D，BRAZIER J，PAISLEY S. NICE DSU [18] BRAZIER J，LONGWORTH L. NICE DSU Technical
technical support document 9：the identification，review Support Document 8：an introduction to the measurement
and synthesis of health state utility values from the litera- and valuation of health for NICE submissions[EB/OL].
ture[EB/OL]. [2022-05-11]. https：//www.sheffield.ac.uk/ [2022-05-11]. https：//www.sheffield.ac.uk/sites/default/
sites/default/files/2022-02/TSD9-HSUV-values_FINAL.pdf. files/2022-02/TSD8-Introduction-to-MVH_final.pdf.
[ 9 ] MOK C H，KWOK H H Y，NG C S，et al. Health state [19] BRIDGES J F P，HAUBER A B，MARSHALL D，et al.
utility values for type 2 diabetes and related complications Conjoint analysis applications in health：a checklist：a
in East and Southeast Asia：a systematic review and meta- report of the ISPOR Good Research Practices for Conjoint
analysis[J]. Value Health，2021，24（7）：1059-1067. Analysis Task Force[J]. Value Health，2011，14（4）：403-
[10] MATZA L S，STEWART K D，LLOYD A J，et al. Vig- 413.
nette-based utilities：usefulness，limitations，and methodo- （收稿日期：2022-02-12 修回日期：2022-05-16）
logical recommendations[J]. Value Health，2021，24（6）： （编辑：孙 冰）

《中国药房》杂志——《化学文摘》（CA）收录期刊，欢迎投稿、订阅

中国药房 2022年第33卷第14期 China Pharmacy 2022 Vol. 33 No. 14 ·1753 ·